Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-15 4:33 pm Sale | 2021-11-15 | 13G | AERPIO PHARMACEUTICALS INC ARPO | RA Capital Management, L.P. | 0 0.000% | -165,749 (Position Closed) | Filing History |
| 2021-11-15 4:32 pm Sale | 2021-11-15 | 13G | ARYA SCIENCES ACQUISITION CORP ARYD | RA Capital Management, L.P. | 0 0.000% | -1,000,000 (Position Closed) | Filing History |
| 2021-11-15 4:31 pm Sale | 2021-11-15 | 13G | ARDELYX INC ARDX | RA Capital Management, L.P. | 0 0.000% | -24,652,344 (Position Closed) | Filing History |
| 2021-11-12 4:30 pm Purchase | 2009-02-28 | 13D | WAVE LIFE SCIENCES LTD WVE | RA Capital Management, L.P. | 7,828,457 13.300% | 5,250 (+0.07%) | Filing History |
| 2021-11-05 4:34 pm Purchase | 2021-10-22 | 13G | XILIO THERAPEUTICS INC XLO | RA Capital Management, L.P. | 109,483 5.700% | 109,483 (New Position) | Filing History |
| 2021-10-28 4:32 pm Purchase | 2009-02-28 | 13D | FORMA THERAPEUTICS HLDGS INC FMTX | RA Capital Management, L.P. | 9,029,184 19.050% | 17,533 (+0.19%) | Filing History |
| 2021-10-28 4:23 pm Purchase | 2009-02-28 | 13D | KALA PHARMACEUTICALS INC KALA | RA Capital Management, L.P. | 438,461 16.850% | 3,476 (+0.80%) | Filing History |
| 2021-10-25 4:35 pm Purchase | 2021-10-13 | 13G | OTONOMY INC OTIC | RA Capital Management, L.P. | 3,092,294 5.500% | 3,092,294 (New Position) | Filing History |
| 2021-10-25 4:34 pm Purchase | 2021-10-13 | 13G | PYXIS ONCOLOGY INC PYXS | RA Capital Management, L.P. | 1,914,934 5.800% | 1,914,934 (New Position) | Filing History |
| 2021-10-01 4:30 pm Purchase | 2021-09-23 | 13G | SYNLOGIC INC SYBX | RA Capital Management, L.P. | 444,444 9.900% | 444,444 (New Position) | Filing History |
| 2021-09-27 4:32 pm Purchase | 2021-09-17 | 13D | DICE THERAPEUTICS INC DICE | RA Capital Management, L.P. | 5,208,911 14.300% | 5,208,911 (New Position) | Filing History |
| 2021-09-27 4:30 pm Purchase | 2021-09-17 | 13D | TYRA BIOSCIENCES INC TYRA | RA Capital Management, L.P. | 7,236,454 17.000% | 7,236,454 (New Position) | Filing History |
| 2021-09-14 4:30 pm Unchanged | 2009-02-28 | 13D | POINT BIOPHARMA GLOBAL INC PNT | RA Capital Management, L.P. | 8,856,018 9.800% | 0 (Unchanged) | Filing History |
| 2021-09-13 4:30 pm Purchase | 2021-09-10 | 13D | ACUMEN PHARMACEUTICALS INC ABOS | RA Capital Management, L.P. | 9,774,551 24.200% | 3,778 (+0.04%) | Filing History |
| 2021-08-23 4:30 pm Purchase | 2021-08-11 | 13G | AERPIO PHARMACEUTICALS INC ARPO | RA Capital Management, L.P. | 165,749 5.220% | 60,762 (+57.88%) | Filing History |
| 2021-08-19 4:30 pm Purchase | 2021-08-09 | 13D | CLIMB BIO, INC. CLYM | RA Capital Management, L.P. | 13,151,959 50.000% | 13,151,959 (New Position) | Filing History |
| 2021-08-18 5:30 pm Purchase | 2009-02-28 | 13D | WAVE LIFE SCIENCES LTD WVE | RA Capital Management, L.P. | 7,823,207 15.390% | 48,000 (+0.62%) | Filing History |
| 2021-08-16 4:32 pm Sale | 2021-08-16 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | RA Capital Management, L.P. | 0 0.000% | -950,238 (Position Closed) | Filing History |
| 2021-08-13 4:31 pm Purchase | 2021-08-03 | 13G | EYEPOINT INC EYPT | RA Capital Management, L.P. | 1,606,859 5.600% | 1,606,859 (New Position) | Filing History |
| 2021-08-13 4:30 pm Purchase | 2021-08-03 | 13G | RXSIGHT INC RXST | RA Capital Management, L.P. | 3,052,796 11.100% | 3,052,796 (New Position) | Filing History |